PharmiWeb.com - Global Pharma News & Resources

Events

Featured Events

Events

Where will you be launching your new orphan medicine? You may be confident that your Global market access strategy will support access in key launch markets like the UK, the EU4 and the US, but have you thought about other markets? Have you looked at the reimbursement requirements for rare disease products in the Nordic markets? Have you explored opportunities in growth markets, such as those in the Middle East and North Africa (MENA) region? This Rare Disease Day, our Global Market Access team will compare and contrast access opportunities and challenges for rare disease treatments in the differing markets of the Nordic and MENA regions, asking: what does this mean for your overarching market access strategy? Join us live at 1.00pm (GMT)/2.00pm (CET)/8.00am (EST) on Thursday 29th February…
Rare disease market access – Launching orphan drugs in secondary markets: the Nordic and MENA regions
05-Mar-2024 - 07-Mar-2024
GPCRs-targeted drug discovery continues to gain exponential momentum, with advances in screening tools, characterization of dynamic confirmations and basic GPCR biology, including orphan receptors. Coupled with numerous strategic collaboration and investment, the GPCR field is fuelling for the clinical progression of next-generation small molecules and biologics across a spectrum of indications and previously undrugged GPCR targets. Owing to this, the Annual GPCRs-Targeted Drug Discovery Summit returns for its 3rd year as the world's only and most comprehensive industry dedicated GPCR forum. Bringing two brand new specialized tracks of content (Target ID and Validation and Hit ID and Optimization), don't miss out on your ultimate chance to unite with 100+ GPCR experts devoted to accelerati…
GCPRs Targeted Drug Discovery Summit
With the cell and gene therapy industry surging, rapid advances in mRNA-based therapies, and the advent of DNA vaccines, the demand for quality DNA as a critical starting and therapeutic material has skyrocketed in recent years. The Inaugural DNA Process Development and Manufacturing Summit is the only forum solely dedicated to increasing plasmid and cell-free based DNA production while reducing costs, time, and ensuring regulatory compliance. Meet 80+ DNA production experts over 3 days packed with deep-dive workshops, data-led presentations, and dedicated discussion and networking sessions to address the most pressing challenges of producing DNA, brought together by our 18+ expert speakers from leading companies like Sanofi, Roche, Genentech, Pfizer and more. If you want to gain higher yi…
DNA Process Development and Manufacturing Summit | Boston, MA | March 5-7, 2024
We are delighted to welcome you to the 17th International Conference on Advanced Technologies and Treatments for Diabetes (ATTD 2024) to be held on 6-9 March 2024 in Florence, Italy. We invite you to be a part of ATTD – the leading international forum – where clinicians, diabetes care providers, researchers, industries, start-up, investors, reimbursement authorities, regulators and people with diabetes, assemble with the goal to ameliorate the care of people with diabetes as the fastest possible pace. Presentations and discussions will be given by many distinguished professionals in the field and will include topics such as artificial intelligence-based decision support systems, glucose sensors, closed-loop systems, artificial pancreas, devices for diabetic prevention, new medications for…
ATTD 2024 - 17th International Conference on Advanced Technologies and Treatments for Diabetes
12-Mar-2024 - 15-Mar-2024
Antibody-drug conjugates are coming of age with a remarkable surge in recent times, which has marked a turning point in their development. Notable achievements include the ground-shaking triumph of ENHERTU, eye-popping investments like Pfizer's monumental $43 billion acquisition of Seagen, and the FDA's greenlight for ELAHERE. These milestones have transformed the ADC landscape, driving increased interest and investment in the field, which now has a preclinical and clinical arena dynamically evolving. As such, the 14th World ADC London returns next March. This will be the first opportunity in the new year to explore these monumental wins, reflect on ongoing challenges, and collaborate on innovative strategies to supercharge all stages of ADC development. Secure regulatory approvals and pos…
14th World ADC London 2024
The Annual Pharma Supply Chain & Security World Summit is back in London for the 6th time, and this time with more focus on optimizing your supply chain challenges to ensure an agile, responsive, streamlined and secured supply chain. The pharmaceutical supply chains are facing a significant challenge in the form of counterfeit drugs that are entering the supply chain from various points at different levels. Pharmaceutical companies that adopt an effective serialisation program have end-to-end visibility and traceability for all of their packaging, labelling, and distribution. This enables them to rapidly identify and quarantine counterfeit products. This helps to protect patients, consumers worldwide, brand equity, reputations and the company's revenue stream by ensuring compliance wit…
Pharma Supply Chain & Security World 2024
19-Mar-2024 - 21-Mar-2024
About Bioprocessing Summit Europe Bioprocessing Summit Europe brings together 750+ upstream, downstream, bioproduction, analytical and formulation professionals to advance the manufacture, quality and control of biological and genetic therapies, and new for 2024, Alternative Proteins such as Cultured Meat. This 3-day, 12 track meeting has quickly become a premier meeting in the European bioprocessing calendar and is regarded by many as “the fastest growing bioprocessing meeting in Europe” following record growth in 2023 – 500 to 700+ attendees – including a sold-out Exhibit Hall of 65 Solution Providers. We look forward to seeing you in Barcelona on 19-21 March 2024, with expanded content on downstream processing, smart and sustainable bioproduction,…
The 4ᵗʰ Wet AMD and Diabetic Eye Disease Drug Development Summit is returning to Boston this March to unite 70+ industry-based retinal vascular experts from the likes of Bayer, Boehringer Ingelheim, Genentech, Novartis and OcuTerra, at the only industry-dedicated forum to transform the potential of treatment of chronic, sight-threatening retinal vascular diseases to improve patient outcomes. Hear fresh perspectives from the new companies speaking at the 2024 meeting including Aviceda Therapeutics, Bayer, Boehringer Ingelheim, OcuTerra, Novartis, Genentech, and Adverum Biotechnologies and discover robust new content focusing on industry-specific topics such as new targets, in vivo and in vitro models, retinal imaging and clinical biomarkers and new modalities for retinal and choroidal neova…
4th Wet AMD and Diabetic Eye Disease Drug Development
Accelerate Your Insight of Mechanisms of Action, Cellular Pathways and Endosomal Escape to Gain Access to Tumor and Cell-Specific Targets Step into the 2nd Targeted Intracellular Delivery Summit, a thrilling exploration of cutting-edge advancements in drug delivery. This year, we redefine possibilities, venturing beyond traditional boundaries with a focus on cellular biology and intracellular mechanisms. Optimize drug delivery, overcome endosomal challenges, and expand therapies beyond the liver with in-depth case studies and a Pre-Conference Workshop Day. Gain insights into targeted cell interventions for cancer and autoimmune diseases, re-thinking innovative delivery platforms and strategies for cargo delivery into novel targets. Engage in transformative discussions and exclusive case st…
2nd Targeted Intracellular Delivery Summit
The last 12 months have highlighted key milestones in European biopharma investment– from GSK injecting €1 million into a 15-building biotech campus in Stevenage, to AstraZeneca investing £1 billion into a new R AND D and Corporate HQ. As the pressure to expand and continue pipeline progression within a scattered and distributed market, there has never been a better time to know how to navigate unknown waters. Emulating the 2023 success, the Lab Asset and Facility Management in Pharma Europe returns for the second year running. This expert-led summit is solely dedicated to imparting expert knowledge with the goal of expediting operational excellence in laboratories across Europe. Join 80+ senior lab, R AND D operations, lab workplace strategy, lab equipment, and asset leaders from the like…
2nd Lab Asset and Facility Management in Pharma Europe
Following the increasing interest in access to investigational medicines from patients, the harmonization of guidance and research on the value of expanded access programs witnesses a critical rise. Back in Boston as the only industry forum defining global regulations for EAP and your definitive networking opportunity to connect with managed access teams from other leading and new companies that are immersing themselves in this evolving field of opportunity and life-changing support. Reunite with 120+ industry experts setting up and leading EAPs at the 4th Operationalize Expanded Access Programs Summit and gain practical take aways on how to construct a reliable system, define a clear exit strategy, understand updated local and global regulations, and determine the role of real-world data…
4th Operationalize Expanded Access Programs Summit
20-Mar-2024 - 21-Mar-2024
This event will discuss how emerging biology and cutting-edge technologies are pioneering the medicines of tomorrow. Bringing together scientists, researchers and entrepreneurs with bold ideas to serve our shared ambitions in creating the next generation of therapeutics to cure more patients around the world. The 2024 R&I meeting – based in Manchester – will comprise the following four main sessions. Track 1 – Animal-free drug discovery. Emma Shepherd (Aston University) & Mike Morton (Apconix) There has been a major shift away from animal use which has been catapulted by recent legislation stating that the FDA will consider approval of new medicines without animal data.  This session will showcase some of the latest innovations and applications of animal-free technologies incl…
ELRIG Research & Innovation 2024
21-Mar-2024 - 21-Mar-2024
7th Annual Pharma Regulatory 2024                        21st March 2024, Hotel Kohinoor Continental Hotel, Mumbai, India   The 7th Annual Pharma Regulatory Summit 2024 congregates foremost global pharmaceutical industry professionals and regulators to share their insights on technologies, approaches, and solutions that will drive innovation and quality for the medicines delivered to patients worldwide. This interactional setting with expert-led regulatory and industry presentations, and forums will ensure pharmaceutical industry professionals are expedient to develop and apply ingenious solutions in today’s global regulatory environment. Please contact me for Sponsor / D…
Pharma Regulatory Summit 2024
Welcome to the International Cancer Research and Drug Discovery Conference (i-Cancer Congress), in London on March 22, 2024. We're excited to bring together healthcare professionals from around the world to discuss the latest developments and innovations. i-Cancer Congress is designed to provide a platform for experts in the field of oncology to share their knowledge, exchange ideas, and collaborate on new research projects. The conference will cover a wide range of topics related to cancer research, diagnosis, treatment, and prevention. With a range of presentations, workshops, and networking opportunities, attendees will have the chance to learn from some of the most accomplished healthcare professionals in the world. In addition to learning from expert speakers, attendees will also have…
International Cancer Research and Drug Discovery Conference (i-Cancer Congress)
EDUCATION IS OUR TOP PRIORITY! With education documentation becoming a way of life and the budget constraints facing many hospitals and institutions, in conjunction with the Society of Interventional Radiology (SIR) and the Association for Radiologic and Imaging Nursing (ARIN), AVIR strives to build an education program that meets and exceeds the expectations of our attendees. The AVIR Annual Scientific Meeting continues to provide an excellent venue for participation and marketing for our corporate sponsors. ABOUT US The Association of Vascular and Interventional Radiographers (AVIR) is a nonprofit, national organization of Radiologic Technologists and allied health professional deeply committed to improving health and the quality of life through the practice of vascular and interventiona…
(AVIR) Association of Vascular and Interventional Radiographers Annual Meeting, March 24-26, 2024
25-Mar-2024 - 27-Mar-2024
Neuroimmunology discovery has continued to expand over the past year, with emerging and continued biology and target investigation against TREM2, RIPK1, ferroptosis, NLRP3, LRRK2, and beyond. However, there are still significant translational barriers to overcome to see clinical success of neuroinflammatory modulators and tackle the huge unmet patient need in neurology. Characterizing and harnessing functions and interactions of microglia, astrocytes, oligodendrocytes, and infiltrating adaptive immune cells are key to discovering and developing therapies to treat underlying neuroinflammation in Alzheimer's, Parkinson's, multiple sclerosis, and beyond. Join 100+ biopharma experts from Alector, Lundbeck, Vigil Neuroscience, Biogen, BMS, Muna Therapeutics, Pipeline Therapeutics, PTC Therapeut…
6th Neuroimmunology Drug Development
This conference will continue to focus and build on the challenges and hurdles that companies working in the microbiome space will have to recognize and navigate in order to successfully commercialize their products. Additionally, this meeting also showcases ground-breaking research being performed by leadings scientist from around the globe. Attendees will have the opportunity to hear the leading companies and academics discuss the work they have underway and how they are meeting these challenges head-on to apply recent discoveries to a variety of disease processes, restoration of health and improved outcomes. Prices:Industry: USD 1595.00,Academic/Government/Clinician: USD 695.00,Student: USD 450.00 Time: 8:00 am to 3:00 pm
The 9th Annual Translational Microbiome Conference